Abbott Laboratories (ABT.N)
ABT.N on New York Stock Exchange
67.59USD
19 Oct 2018
67.59USD
19 Oct 2018
Change (% chg)
$-0.55 (-0.81%)
$-0.55 (-0.81%)
Prev Close
$68.14
$68.14
Open
$68.18
$68.18
Day's High
$68.65
$68.65
Day's Low
$67.23
$67.23
Volume
2,666,328
2,666,328
Avg. Vol
1,592,244
1,592,244
52-wk High
$74.15
$74.15
52-wk Low
$53.67
$53.67
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.81 | December | 21 Oct 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 8 | 8 | 8 | 8 |
| (2) OUTPERFORM | 7 | 6 | 6 | 7 |
| (3) HOLD | 4 | 4 | 4 | 4 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.79 | 1.78 | 1.78 | 1.79 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 17 | 7,822.51 | 7,920.00 | 7,733.00 | 7,772.24 |
| Quarter Ending Mar-19 | 10 | 7,650.26 | 7,868.10 | 7,507.00 | 7,439.55 |
| Year Ending Dec-18 | 18 | 30,656.20 | 31,041.00 | 30,546.00 | 30,191.70 |
| Year Ending Dec-19 | 19 | 32,238.40 | 33,225.00 | 31,769.50 | 31,934.60 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 19 | 0.81 | 0.82 | 0.80 | 0.79 |
| Quarter Ending Mar-19 | 13 | 0.66 | 0.75 | 0.63 | 0.64 |
| Year Ending Dec-18 | 21 | 2.88 | 2.90 | 2.86 | 2.82 |
| Year Ending Dec-19 | 21 | 3.20 | 3.26 | 3.11 | 3.18 |
| LT Growth Rate (%) | 6 | 11.47 | 13.00 | 7.10 | 11.46 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Sep-18 | 7,650.64 | 7,656.00 | 5.36 | 0.07 |
| Quarter Ending Jun-18 | 7,711.53 | 7,767.00 | 55.47 | 0.72 |
| Quarter Ending Mar-18 | 7,285.94 | 7,390.00 | 104.06 | 1.43 |
| Quarter Ending Dec-17 | 7,385.90 | 7,589.00 | 203.10 | 2.75 |
| Quarter Ending Sep-17 | 6,716.81 | 6,829.00 | 112.19 | 1.67 |
| Earnings (per share) | ||||
| Quarter Ending Sep-18 | 0.75 | 0.75 | 0.00 | 0.58 |
| Quarter Ending Jun-18 | 0.71 | 0.73 | 0.02 | 2.86 |
| Quarter Ending Mar-18 | 0.58 | 0.59 | 0.01 | 1.71 |
| Quarter Ending Dec-17 | 0.73 | 0.74 | 0.01 | 1.07 |
| Quarter Ending Sep-17 | 0.65 | 0.66 | 0.01 | 1.18 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 7,822.51 | 7,953.22 | 7,960.79 | 7,967.69 | 7,772.24 |
| Quarter Ending Mar-19 | 7,650.26 | 7,667.15 | 7,666.65 | 7,683.99 | 7,439.55 |
| Year Ending Dec-18 | 30,656.20 | 30,754.60 | 30,767.90 | 30,776.90 | 30,191.70 |
| Year Ending Dec-19 | 32,238.40 | 32,491.10 | 32,527.30 | 32,556.00 | 31,934.60 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 0.81 | 0.82 | 0.82 | 0.82 | 0.79 |
| Quarter Ending Mar-19 | 0.66 | 0.67 | 0.67 | 0.67 | 0.64 |
| Year Ending Dec-18 | 2.88 | 2.89 | 2.89 | 2.89 | 2.82 |
| Year Ending Dec-19 | 3.20 | 3.24 | 3.23 | 3.23 | 3.18 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Dec-18 | 0 | 16 | 0 | 16 |
| Quarter Ending Mar-19 | 3 | 5 | 3 | 4 |
| Year Ending Dec-18 | 2 | 15 | 2 | 15 |
| Year Ending Dec-19 | 3 | 15 | 3 | 15 |
| Earnings | ||||
| Quarter Ending Dec-18 | 0 | 9 | 0 | 10 |
| Quarter Ending Mar-19 | 1 | 6 | 1 | 4 |
| Year Ending Dec-18 | 5 | 5 | 6 | 7 |
| Year Ending Dec-19 | 3 | 14 | 4 | 14 |
Earnings vs. 
Estimates